Catalyst Pharmaceuticals, Inc.
CPRX
Revenue
122.71M
▲24.20M▲24.57%
3 Months ChangeAssets
706.36M
▲59.68M▲9.23%
3 Months ChangeLiabilities
97.71M
▲12.44M▲14.59%
3 Months ChangeFree Cash Flow
31.73M
▲19.73M▲164.47%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-26
Form 8-K
ID: 0001193125-24-226538
2024-08-07
Form 8-K
ID: 0001193125-24-195950
2024-08-07
Form 10-Q
ID: 0000950170-24-092745
2024-07-26
Form 8-K
ID: 0001193125-24-186261
2024-05-30
Form 8-K
ID: 0001193125-24-150433
2024-05-21
Form 8-K
ID: 0001193125-24-144049
2024-05-08
Form 8-K
ID: 0001193125-24-134303
2024-05-08
Form 10-Q
ID: 0001193125-24-134195
2024-03-13
Form 8-K
ID: 0001193125-24-066931
2024-02-29
Form 8-K
ID: 0001193125-24-051235